PPIDT00354
Drug Information
| Name | Etelcalcetide |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB12865 |
| Type | small molecule |
| Indication | Etelcalcetide is a calcium-sensing receptor agonist indicated for: Secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, solution | Intravenous |
10 mg/2mL
|
| Injection, solution | Intravenous |
10 mg
|
| Injection, solution | Intravenous |
2.5 mg
|
| Injection, solution | Intravenous |
2.5 mg/0.5mL
|
| Injection, solution | Intravenous |
5 mg
|
| Injection, solution | Intravenous |
5 mg/1mL
|
| Injection, solution | Intravenous; Parenteral |
10 MG
|
| Injection, solution | Intravenous; Parenteral |
2.5 MG
|
| Injection, solution | Intravenous; Parenteral |
5 MG
|
| Solution | Intravenous |
10 mg
|
| Solution | Intravenous |
2.5 mg
|
| Solution | Intravenous |
5 mg
|
| Injection, solution | Intravenous |
5 mg/mL
|
| Injection, solution | — |
10 mg/2ml
|